Thionylchloride mediated esterification from L-and D-serine with methanol yielded methyl esters 4a and 4b respectively. Reaction of ethylbenzimidate hydrochloride 5 with 4 and 1.15 eq. of NEt 3 at room temperature in methylene chloride formed phenyloxazoline stereoisomers 6 in 84 % for 6a and 83 % for 6b. In the following step the methyl ester was converted into the primary alcohol 7 by treatment with 2 eq. DIBAL and transformed into the azide 8 via mesyl activation and substitution by NaN 3 . The phenyloxazoline was cleaved at 60 °C in 4 N HCl within 5 h resulting in 1-azido-desoxy serinol 9. However, due to its low stability even at -20 °C 9 needed to be directly converted in 3. After formation of the amide bond with oleic acid, the resulting 3 proved to be stable. The enantiomeric purity was determined via esterification with R-Mosher's acid forming the esters 10 from 3a and 11 from 3b. In correlation with the specific rotation the 19 F-NMR indicated an enantiomer excess (ee) of 92 for 3a and 95 for 3b.
171.7 (C-1), 166.4 (C-1'), 132.0 (C-5'), 128.7 (C-4'), 128.5 (C-3'), 127.0 (C-2'), 69.6 (C-3), 68.7 (C-2), 52.8 (C-1'') ppm. MS-MALDI (+) General procedure for the preparation of (2-Phenyl-4,5-dihydrooxazol-4-yl)methanol 7. 2-Phenyl-4,5-dihydrooxazole-4-carboxylic acid methyl ester 6 (1.00 eq) was solved in thf (2.00 mL per mmol 6) and cooled to 0 °C. Now a 1.00 M solution of diisobutyl-aluminum hydride in cyclohexane were added dropwise over 20 min (2 eq). The resulting mixture was allowed to warm to room temperature and was stirred for 6 h. The reaction was cooled to 0 °C and was quenched with ethyl acetate and afterwards a half-saturated solution of Potassium sodium tartrate aq.
(1 mL per mmol 6) was added. The mixture was stirred vigorously overnight at room temperature. The phases were separated and the aqueous phase was extracted with ethyl acetate (three times with 2.00 ml per mmol 6). The organic phases were combined dried over Na 2 SO 4 and concentrated under reduced pressure. The residue was purified via column chromatography (ethyl acetate).
R- : 44.7 (c = 1, MeOH).
S-(2-Phenyl-4,5-dihydrooxazol-4-yl)methanol 7b. General procedure gave 7b as colorless solid. Yield: 94 %. R f : 0.12 (ethyl acetate). 1 H-NMR: (400 MHz, MeOD): δ = 7. 94-7.91 (m, 2H, H-3'), 7.55-7.51 (m, 1H, H-5'), 7.46-7.42 (m, 2H, H-4') , 4.54 (dd, 2 J = 7.9, 3 J = 9.4 Hz, 1H, H-3a), 4.41 (dd, 2 J = 7.8, 3 J = 7.1 Hz, 1H, H-3b), 4.40-4.34 (m, 1H, H-2), 3.73 (dd, 2 J = 11.3, 3 J = 3.9 Hz, 1H, H-1a), 3.68 (dd, 2 J = 11.3, 3 J = 5.0 Hz, 1H, H-1b) ppm. 13 C-NMR: (100 MHz, MeOD): δ = 167.2 (C-1'), 132.9 (C-5'), 129.5 (C-4'), 129.4 (C-3'), 128.5 (C-2'), 71.2 (C-3), 69.0 (C-2), 64. : 48.5 (c = 1, MeOH).
General procedure for the preparation of (2-Phenyl-4,5-dihydrooxazol-4-yl)methyl methane sulfonate 12. (2-phenyl-4,5-dihydrooxazol-4-yl)methanol 11 (1.00 eq) and trimethylamine (1.20 eq) were solved in CH 2 Cl 2 (7.00 mL per mmol 11). The mixture was cooled to 0 °C and methane sulfonyl chloride was added dropwise over 10 min. the resulting mixture was allowed to warm to room temperature and was stirred for 2 h. The reaction was quenched with 0.10 M HCl aq. (2.00 ml per mmol 11) and the phases were separated. The aqueous phase was extracted with CH 2 Cl 2 (4 times with 2.00 ml per mmol 11). The organic phases were combined, washed with saturated NaHCO 3 (2.00 ml per mmol 11), dried over Na 2 SO 4 and filtrated. Evaporation of the solvents provided crude 12 that was used in the next reaction without any further purification.
General procedure for the preparation of 4-(azido methyl)-2-phenyl-4,5-dihydrooxazole 8. Crude (2-phenyl-4,5-dihydrooxazol-4-yl)methyl methane sulfonate 12 was solved in dmf (3.50 ml per mmol 12), NaN 3 (5.00 eq) was added and the mixture was stirred over night at 70 °C. The mixture was concentrated under reduced pressure and diluted in H 2 O (15 ml per mmol 12). The aqueous phase was extracted with diethyl ether (four times with 10 ml per mmol 12) the layers were separated, the organic phases combined, dried over Na 2 SO 4 , filtrated and the solvents removed under reduced pressure. The crude product was purified by column chromatography (cyclohexane/ethyl acetate 2 : 1) to provide 4-(azido methyl)-2-phenyl-4,5-dihydrooxazole. General procedure for the preparation of 2-amino-3-azidopropan-1-ol hydrochloride 9. 4-(azido methyl)-2-phenyl-4,5-dihydrooxazole 8 was solved in 4 N HCl aq. (5.00 ml per mmol 8) and stirred for 5 h at 60 °C. After cooling to room temperature, the aqueous layer was washed with methylene chloride (three times with 5.00 ml per mmol 8). The phases were separated and the aqueous Layer was concentrated under reduced pressure. The brown oil 8 was directly used as crude product in the next step without any further purification. General procedure for the preparation of Mosher ester 21 and 22. MTPA (2.50 eq) was solved in methylene chloride (15 ml per mmol 3) and added dropwise to a solution of 3 (1.00 eq), DCC (2.50 eq) and DMAP (2.50 eq) in methylene chloride (15 ml per mmol 3). The mixture was stirred for 14 h at room temperature. The mixture was filtered over a short plug of silica gel, washed with ethyl acetate (100 mL per mmol 3), the solvents removed under reduced pressure and the crude product purified via column chromatography (cyclohexane/ethyl acetate 10 : 1) to yield 10 respectively 11. Peripheral blood monocytic cells from healthy donors were subjected to Ficoll gradient centrifugation and were used as source for primary human T cells (enriched by nylon wool columns). Primary human and Jurkat T cells were maintained in RPMI1640/10 % FCS. 
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Endothelial cell lines
The simian virus 40 large T antigen-transformed human brain microvascular endothelial cells (HBMEC) were cultured as previously described. Briefly, HBMECs were cultured in RPMI-1640 medium (Gibco Life Technologies) supplemented with FCS (10 %) (Gibco Life Technologies), Nu serum IV (10 %; Becton Dickinson), vitamins (1 %), non-essential amino acids (1 %), sodium pyruvate (1 mM), L-glutamine (2 mM), heparin (5 U ml -1 ) (all reagents were from Biochrom) and endothelial cell growth supplement (30 mg ml -1 ) (Cell Systems Clonetics). Cultures were incubated in a humid atmosphere at 37 °C with 5% CO 2 . Cells between the 10th and 25th passages were used for infection assays. HBMEC were cultured in T25 flasks (Corning Costar Corporation, Cambridge, MA, USA) to a confluent monolayer. At 48 hours prior to treatment, HBMEC were split and seeded on gelatine-coated 24-well tissue culture plates (Sarstedt; Germany) at a density of 5×10 4 cells per well. Cells were grown to approximately 1×10 5 cells prior to treatment.
Primary astrocytes and 3T3 fibroblasts
Primary cultures of astrocytes were prepared from newborn mouse brain and cultivated in DMEM/10 % FCS as described in [ref5] . 3T3 fibroblasts were purchased from ATCC (CRL-1658) and also cultivated in DMEM/10 % FCS. To stop cell division, astrocytes and fibroblasts were grown in serum-free DMEM medium for 24 h prior to incubation with 3a/b and click reaction.
Apoptosis Analysis
HBMEC were seeded in 24-well tissue culture plates to a density of 2 × 10 6 cells/well. The medium was changed and cells were treated with the compounds for 1 h or 16 h, respectively. Cells were harvested and washed once with 1 x PBS -/-and once with Annexin V binding buffer (BD Biosciences). Cells were resuspended and transferred into a 500 µL siliconized polypropylene tube. Annexin V-Alexa Fluor 488 (Molecular Probes) was added at a 1:20 dilution and cells were incubated for 15 min at RT. Following this, propidium iodide (PI) was added at a final concentration of 1 µg/mL and cells were stained for a further 15 min at RT. After staining, cells were washed twice with PBS -/-and fixed with 2 % formaldehyde for 10 min on ice. Following fixation, cells were washed twice with PBS -/-and treated with 50 µg/mL DNase-free RNase (Sigma, R4642) for 15 min at 37 C. Cells were then washed once with PBS -/-and immediately analyzed using a BD FACSCalibur TM flow cytometer (BD Biosciences) and BD CellQuest TM Pro Software (BD Biosciences). For each measurement, at least 10,000 cells were counted. Cells that stained positive for annexin V represented cells with intact membranes and externalized phosphatidylserine (early apoptosis) and cells positive for annexinV/PI represent cells that had lost membrane integrity (late apoptosis/necrosis). Confocal Laser Scanning Microscopy (CLSM) imaging was performed using a LSM 780 (Zeiss, Germany), equipped with an incubation system and a 40x Plan-Apochromat oil objective (NA 1.4) and laser line 488. Images were processed using CLSM software ZEN2012.
Fig S3
Jurkat T cells were incubated with 25µM 3b in HBSS for 30min at rt. After washing, the cells were exposed to 20µM DIBO488 dye and the click reaction was performed for 5min at rt and then excess dye was washed away three times with HBSS. For following 3b through cell compartments, cells were kept at 37 °C for 5, 60 and 180 min before microscopic analysis.
concentrations of 2, 3a, 3b for 1 h (A) or 16 hrs (B). Apoptosis was quantified using flow cytometry after staining with
Fig S4
Jurkat T cells were incubated with 25 µM 3a in HBSS for 30 min at rt. After washing, the cells were exposed to 20 µM DIBO488 dye and the click reaction was performed for 5 min at rt. Cells were washed three times with HBSS and kept at rt until microscopic analysis.
Fig S5
Jurkat T cells were incubated with 25 µM 3b and 5 µM NBD-C6-cer in HBSS for 30 min at 37 °C. After washing, the cells were exposed to 20 µM DBCO sulfo Cy5 dye and the click reaction was performed for 5 min at rt. Cells were washed three times with HBSS and kept at rt until microscopic analysis.
Fig S6
HBMEC were treated with 5 µM 3b in RPMI for 30 min. After washing, the cells were exposed to 5 µM DBCO-sulfoCy5 + NBD C6 for 30 min at 37 °C. Cells were washed three times with PBS and kept at RT until microscopic analysis.
Fig S7
Primary cultured astrocytes were incubated with 5 µM each 3a and b for 1 h, washed with PBS, and then click reaction performed with 5 µM Alexa 546 DIBO alkyne for 20 min at RT. After washing, cells were fixed with pformaldehyde/glutaraldehyde and permeabilized under mild conditions (0.2 % Triton X-100/PBS, 5 min, RT). Immuncytochemistry and co-labeling was performed with anti-GM130 mouse IgG and Alexa 488 anti-mouse IgG.
